Arnold & Porter
Campaign Finance$4,865,409 Given
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
- Employee Color Block
- PAC Color Block
Republicans vs. Democratsin dollars. "Other" includes 3rd parties and organizations without official party affiliation.
State vs. Federalin dollars
Top PAC Recipients
- Employee Color Block
- PAC Color Block
Bundled ContributionsMoney raised by the firm from multiple donors on behalf of the recipient. The firm's own contributions are not included.
Recipient Lobbyist Amount Henry A. Waxman $23,550
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying Carried Out by Arnold & Porter
Names of Lobbyists
Client Amount Altria Client Services $5,130,000 Philip Morris Management $1,920,000 Pharmaceutical Rsrch & Mfrs of America $1,890,000 Energy Future Holdings Corp $1,790,000 State Farm Insurance $1,400,000 Coalition for Encryption Reform $1,260,000 Hoffmann-La Roche $1,100,000 Altria Corporate Services $1,100,000 Lloyd's of London $1,080,000 Recording Industry Assn of America $1,000,000
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Medicare & Medicaid,
- Energy & Nuclear Power,
- Fed Budget & Appropriations,
- Copyright, Patent & Trademark
Most Frequently Disclosed Bills
Bill No. Title H.R.235 Social Security Fairness Act of 2009 S.484 Social Security Fairness Act of 2009 S.490 Public Servant Retirement Protection Act of 2009 H.R.3849 Disclosure of Presidential Declassification of Intelligence Information Act of 2009 H.R.2091 Freight Rail Infrastructure Capacity Expansion Act of 2011 S.371 Focusing Resources, Economic Investment, and Guidance to Help Transportation Act of 2011 H.R.1108 Family Smoking Prevention and Tobacco Control Act H.R.3849 Box Elder Utah Land Conveyance Act S.625 Family Smoking Prevention and Tobacco Control Act S.3217 Private Fund Investment Advisers Registration Act of 2010
Recent Lobbying Contracts
Date Client Summary Oct. 17, 2013 Society for Excellence in Eyecare Issues related to improving healthcare policy. View registration
RegulationsMentioned in 135 dockets; Submitted to 29 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Arnold & Porter" in public comments on proposed federal regulations.
Documents Submitted by the Organization
View all submissions data for Arnold & Porter
- Toggle 7 FDA Patent Extension Application for KEPIVANCE (palifermin), U.S. Patent No. 5,677,278 2005
- Toggle 5 FSOC Recommendation Regarding Money Market Mutual Fund Reform 2012
- Toggle 3 FDA Stay effective date of approval for NDA 20-932 Roxicodone 1999
- Toggle 2 CFPB Regulation Z; Truth in Lending 2011
- Toggle 2 FDA Review New Drug Applications for Mixtures of Estrogens 1998
- Toggle 2 FDA Request for Stay Granting Provisional Market Exclusivity and Patent Listing for Ziana-CLOSED 2007
- Toggle 2 FDA Patent Listing and Market Exclusivity for Combination Drugs When One Component is a pre-1997 Antibiotic Ingredient; CLOSED: 8/10/2011 2007
- Toggle 2 FSOC Advance Notice of Proposed Rulemaking Regarding Authority to Require Supervision and Regulation of Certain Nonbank Financial Companies 2010
- Toggle 1 CFPB HIGH-COST MORTGAGE AND HOMEOWNERSHIP COUNSELING AMENDMENTS TO THE TRUTH IN LENDING ACT (REGULATION Z) AND HOMEOWNERSHIP COUNSELING AMENDMENTS TO THE REAL ESTATE SETTLEMENT PROCEDURES ACT (REGULATION X) 2012
- Toggle 1 FDA Bioequivalence Requirements for Generic Versions of Solodyn - CLOSED 2008
Mentions in Document Text
View all mentions data for Arnold & Porter
- Toggle 16 EPA Diesel Engine Settlement 2003
- Toggle 12 DOT Braniff Airways, Inc. - Employee Protection Program Investigation 2006
- Toggle 9 FDA Patent Extension Application for KEPIVANCE (palifermin), U.S. Patent No. 5,677,278 2005
- Toggle 5 FDA Review New Drug Applications for Mixtures of Estrogens 1998
- Toggle 5 EPA Land Disposal Restrictions; Treatment Standards for Spent Potliners from Primary Aluminum Reduction (K088); Final Rule 1998
- Toggle 5 FDA Stay effective date of approval for NDA 20-932 Roxicodone 1999
- Toggle 4 FDA Request for Stay Granting Provisional Market Exclusivity and Patent Listing for Ziana-CLOSED 2007
- Toggle 4 FDA OTC Nasal Decongestants 1976
- Toggle 4 DOT Trans World Airlines, Inc. v. City and County of Denver, Colorado-Complaint and Brief-Airport Fee Dispute 1995
- Toggle 3 FDA Approve ANDA for Cefuroxime Axetil Products 2000
Advisory Committees5 people on 5 committees
Data is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.
The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.
Table shows employees of "Arnold & Porter" that sat on federal advisory committees.
- Toggle Commodity Futures Trading Commission 1 person on 1 committee
- Toggle Department of Labor 1 person on 1 committee
- Toggle Department of State 1 person on 1 committee
- Toggle National Endowment for the Arts 1 person on 1 committee
- Toggle Department of the Treasury 1 person on 1 committee